Updated
Updated · Simply Wall St · Aug 27
IMAX Trades at $52.76 After Mann Deal as Valuation Models Diverge by About 19%
Updated
Updated · Simply Wall St · Aug 27

IMAX Trades at $52.76 After Mann Deal as Valuation Models Diverge by About 19%

3 articles · Updated · Simply Wall St · Aug 27

Summary

  • IMAX closed at $52.76 after Mann Theatres agreed to add the first IMAX auditorium at its Plymouth Grand 15 site in Minnesota, keeping the stock in focus despite a slight pullback over the past week.
  • Two valuation yardsticks now point in opposite directions: a widely followed fair-value estimate puts IMAX at $52.73—about 10% overvalued on that framework—while a DCF model values the shares at $58.13, roughly 9% above the market price.
  • Momentum has stayed strong, with IMAX up 16.96% over 30 days, 46.47% year to date and 82.18% on a one-year total shareholder return basis, suggesting investors are backing its longer-term growth story.
  • That case rests on broader content offerings, including local-language films, concerts and live events, plus deeper ties with Apple, Amazon and Netflix that could lift per-screen contribution and margins.
  • Risks still center on softer film slates and weaker theater attendance, which could hit box-office-linked revenue and test whether IMAX can justify its premium earnings multiple.

Insights

With IMAX valuation sparking intense debate, are investors ignoring a massive bubble hidden behind record-breaking box office numbers?
As streaming giants partner with premium theaters, will IMAX expansion strategies redefine cinema or financially drain local chains?